The Serum Institute of India has been at the center of vaccine production for COVID-19. But as the second wave crashes down on the country, an export ban via the Indian central government has put the company in a tough spot, with CEO Adar Poonawalla even fleeing to London. SII is at a point where it no longer holds the promise of production monopoly, and must expand to newer geographies and technology to strengthen its position as a global biotech company.
Story originally reported by Seema Singh https://the-ken.com/story/adar-poonawallas-bid-to-vaccinate-serum-institute-against-all-threats/
News clips sourced from NDTV.
Music and editing by Sameer Rahat from Baqsa Studios.
Special offer for our podcast listeners: https://the-ken.com/podcastoffer/
Follow us on twitter: https://twitter.com/TheKenWeb
Psst share your feedback with us on firstname.lastname@example.org